基因变异在糖尿病中的可行性:核心方面和应用例子
Sarah Yvonnet1,2, Pauline Kromann Reim2, Anne Cathrine Baun Thuesen2
1Medical Museion, Department of Public Health Sciences, University of Copenhagen, Copenhagen, Denmark.
概括
针对糖尿病的精准医学需要明确的标准来确定可操作的遗传变异. 这项研究提出了一个框架,以弥合基因组研究和糖尿病治疗临床实践之间的差距.
科学领域:
- 遗传学 遗传学 是一个
- 医学哲学 医学哲学
- 生物医学科学 生物医学科学
背景情况:
- 由于糖尿病的复杂性和异质性,糖尿病的分类 (第1型,第2型) 不足.
- 基因组技术为精确的糖尿病医学提供了潜力,但临床实施面临挑战.
- 遗传变异的"可操作性"概念缺乏明确的跨学科定义.
研究的目的:
- 开发一个框架来评估糖尿病中遗传变异的可操作性.
- 弥合糖尿病基因组研究与临床实践之间的翻译差距.
- 定义基因变异在糖尿病管理中可采取行动的标准.
主要方法:
- 医学哲学与生物医学科学之间的合作努力.
- 关于基因可操作性的科学,医学和哲学文献的审查.
- 案例研究分析,以评估糖尿病治疗和管理中的可行性.
主要成果:
- 确定了糖尿病遗传变异可操作性的核心方面.
- 突出了研究和临床实践之间关于遗传数据的紧张关系.
- 评估将遗传发现转化为糖尿病可行的临床见解的挑战.
结论:
- 需要一个强大的框架来定义和评估基因变异在糖尿病护理中的可操作性.
- 弥合研究与实践之间的差距对于实现糖尿病精准医学至关重要.
- 清晰的可操作性标准将改善糖尿病的诊断准确性和治疗策略.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Management and Pharmacotherapy
362
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
362
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Diabetes: Symptoms, Diagnosis, and Complications
687
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
687
Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K


